Cargando…

Effect of Biologics on Cardiovascular Inflammation: Mechanistic Insights and Risk Reduction

It is increasingly recognized that atherosclerosis and consequently cardiovascular disease (CVD) are closely linked with inflammatory processes. The latter is in the center of the pathogenic mechanism underlying autoimmune rheumatic diseases (ARD). It follows then, that optimal control of inflammati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fragoulis, George E, Soulaidopoulos, Stergios, Sfikakis, Petros P, Dimitroulas, Theodoros, Kitas, George D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131071/ https://www.ncbi.nlm.nih.gov/pubmed/34017189 http://dx.doi.org/10.2147/JIR.S282691

Ejemplares similares

The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis
por: Soulaidopoulos, Stergios, et al.
Publicado: (2018)

Association Between Uric Acid and Worsening Peripheral Microangiopathy in Systemic Sclerosis
por: Pagkopoulou, Eleni, et al.
Publicado: (2021)

Arterial stiffness correlates with progressive nailfold capillary microscopic changes in systemic sclerosis: results from a cross-sectional study
por: Soulaidopoulos, Stergios, et al.
Publicado: (2019)

The Double-Edged Sword of T1-Mapping in Systemic Sclerosis—A Comparison with Infectious Myocarditis Using Cardiovascular Magnetic Resonance
por: Markousis-Mavrogenis, George, et al.
Publicado: (2020)

Asymmetric Dimethylarginine as a Surrogate Marker of Endothelial Dysfunction and Cardiovascular Risk in Patients with Systemic Rheumatic Diseases
por: Dimitroulas, Theodoros, et al.
Publicado: (2012)

Cardiovascular Magnetic Resonance Reveals Cardiac Pathophysiology in Autoimmune Rheumatic Diseases
por: Markousis-Mavrogenis, George, et al.
Publicado: (2021)

Cardiovascular Magnetic Resonance Identifies High-Risk Systemic Sclerosis Patients with Normal Echocardiograms and Provides Incremental Prognostic Value
por: Markousis-Mavrogenis, George, et al.
Publicado: (2019)

Monitoring and Managing Cardiovascular Risk in Immune Mediated Inflammatory Diseases
por: Anyfanti, Panagiota, et al.
Publicado: (2021)

Do Interleukin-1 and Interleukin-6 Antagonists Hold Any Place in the Treatment of Atherosclerotic Cardiovascular Disease and Related Co-Morbidities? An Overview of Available Clinical Evidence
por: Dimosiari, Athina, et al.
Publicado: (2023)

Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation
por: Dimitroulas, Theodoros, et al.
Publicado: (2017)

Different systemic rheumatic diseases as risk factors for COVID-19-related mortality
por: Fragoulis, George E., et al.
Publicado: (2022)

The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study
por: Sandoo, Aamer, et al.
Publicado: (2012)

Symmetric Dimethylarginine Is Not Associated with Cumulative Inflammatory Load or Classical Cardiovascular Risk Factors in Rheumatoid Arthritis: A 6-Year Follow-Up Study
por: Dimitroulas, Theodoros, et al.
Publicado: (2015)

The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice
por: Kravvariti, Evrydiki, et al.
Publicado: (2019)

The Role of Nutrition in Cardiovascular Disease: Current Concepts and Trends
por: Tyrovola, Dimitra, et al.
Publicado: (2023)

Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction
por: Markousis-Mavrogenis, George, et al.
Publicado: (2021)

Combined Brain-Heart Magnetic Resonance Imaging in Autoimmune Rheumatic Disease Patients with Cardiac Symptoms: Hypothesis Generating Insights from a Cross-Sectional Study
por: Markousis-Mavrogenis, George, et al.
Publicado: (2020)

Higher frequency but similar recurrence rate of uveitis episodes in axial spondylarthritis compared to psoriatic arthritis. A multicentre retrospective study
por: Kougkas, Nikolaos, et al.
Publicado: (2023)

Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment
por: Fragoulis, George E, et al.
Publicado: (2019)

The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era
por: Evangelatos, Gerasimos, et al.
Publicado: (2022)

Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus
por: Fragoulis, George E., et al.
Publicado: (2020)

Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
por: Arida, Aikaterini, et al.
Publicado: (2018)

Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes
por: Kastritis, Efstathios, et al.
Publicado: (2020)

Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools
por: Drosos, George C, et al.
Publicado: (2023)

Pulmonary Arterial Hypertension in Connective Tissue Disorders: The emerging role of screening and early diagnosis. A position paper for Greek Rheumatologists
por: Demerouti, Eftychia, et al.
Publicado: (2019)

Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE
por: Panopoulos, Stylianos, et al.
Publicado: (2023)

Aspirin for Primary Prevention of Cardiovascular Diseases: “WALTZ” with the Evidence
por: Dimitriadis, Kyriakos, et al.
Publicado: (2022)

Nailfold Videocapillaroscopy for the Evaluation of Peripheral Microangiopathy in Rheumatoid Arthritis
por: Anyfanti, Panagiota, et al.
Publicado: (2022)

Tofacitinib as a Promising Therapeutic Option in Refractory Autoimmune-Mediated Vascular and Sclera Inflammation
por: Dimitroulas, Theodoros
Publicado: (2023)

Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients
por: Roelsgaard, Ida K, et al.
Publicado: (2020)

Practical Issues in Managing Systemic Inflammatory Disorders During the COVID-19 Pandemic
por: Dimitroulas, Theodoros, et al.
Publicado: (2020)

Review article: Update on current and emergent data on hepatopulmonary syndrome
por: Soulaidopoulos, Stergios, et al.
Publicado: (2018)

Effectiveness and Safety of Certolizumab Pegol in Axial Spondyloarthritis in a Real-World Setting in Greece: A Sub-Analysis of the Prospective Non-Interventional CIMAX Cohort Study
por: Katsifis, Gkikas, et al.
Publicado: (2022)

Late-Onset Psoriatic Arthritis: Are There Any Distinct Characteristics? A Retrospective Cohort Data Analysis
por: Gialouri, Chrysoula G., et al.
Publicado: (2023)

Breast cancer therapy and cardiovascular risk: focus on trastuzumab
por: Sandoo, Aamer, et al.
Publicado: (2015)

The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study
por: Sandoo, Aamer, et al.
Publicado: (2012)

Combined Brain/Heart Magnetic Resonance Imaging in Systemic Lupus Erythematosus
por: Mavrogeni, Sophie, et al.
Publicado: (2020)

Arterial hypertension assessed “out-of-office” in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated “white coat” phenomenon
por: Protogerou, Athanase D, et al.
Publicado: (2013)

Updated Greek Rheumatology Society Guidelines for the Management of Rheumatoid Arthritis
por: Vassilopoulos, Dimitrios, et al.
Publicado: (2020)

Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice
por: Gialouri, Chrysoula G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ulb8crbtv0tgfdk2rl6c8hfkhf